Pharmacom Labs Sibutramine 15mg x 50 tablets

£41.00

Description
Reviews (0)

Pharmacom Labs Sibutramine 15mg x 50 tablets

Pharmacom Labs Sibutramine 15mg x 50 tablets delivers pharmaceutical-grade sibutramine hydrochloride, a potent non-steroidal anorexigenic agent originally marketed under the brand name Meridia by Abbott Laboratories in 1998. This compound functions as a direct serotonin and norepinephrine reuptake inhibitor, structurally similar to amphetamine, designed specifically for comprehensive obesity treatment and weight management in overweight patients. Sibutramine operates through a dual-action mechanism that targets both appetite suppression and metabolic stimulation. It inhibits the reuptake of serotonin and norepinephrine from the synaptic gap, significantly enhancing the feeling of satiety and reducing daily caloric intake. Clinical studies demonstrate that treated patients reduced daily food consumption by approximately 1,300 calories. Sibutramine stimulates metabolism and increases thermogenesis through indirect activation of beta-3-adrenoreceptors, the receptors responsible for fat oxidation and energy expenditure.

Following hepatic metabolism, sibutramine converts into active metabolites that demonstrate even greater potency in inhibiting neurotransmitter reuptake than the parent compound itself. This metabolic enhancement creates a powerful fat-burning environment while simultaneously controlling hunger cravings. The 15mg dosage provides optimal efficacy for sustained appetite management, while the 50-tablet supply ensures a complete treatment cycle for significant body composition changes.

Key Features

Dual-Action Mechanism: Combines appetite suppression with metabolic thermogenesis for comprehensive weight loss
Neurotransmitter Modulation: Potent serotonin and norepinephrine reuptake inhibitor structurally similar to amphetamine
Proven Efficacy: Clinical studies show reduction of daily caloric intake by up to 1,300 calories
Beta-3 Activation: Stimulates fat burning through indirect impact on beta-3-adrenoreceptors
Active Metabolites: Hepatic conversion creates metabolites with enhanced reuptake inhibition potency
Non-Steroidal Formula: Safe for users seeking weight loss without hormonal side effects
Pharmaceutical Heritage: Original Meridia compound manufactured to strict Abbott Laboratories standards
Comprehensive Treatment: Designed for long-term obesity management and overweight maintenance protocols

Product Specifications

Product Name: Pharmacom Labs Sibutramine 15mg
Active Ingredient: Sibutramine Hydrochloride
Concentration: 15mg per tablet
Package Size: 50 tablets (750mg total content)
Chemical Class: Non-steroidal anorexigenic (Serotonin/Norepinephrine reuptake inhibitor)
Structural Analog: Amphetamine-like structure
Original Brand: Meridia (Abbott Laboratories, 1998)
Mechanism: Appetite suppression + thermogenic metabolic stimulation
Caloric Reduction: Up to 1,300 calories daily reduction in clinical studies
Metabolic Pathway: Hepatic conversion to active metabolites
Target Receptors: Beta-3-adrenoreceptors (indirect stimulation)
Administration: Oral only
Cycle Duration: Typically 4-6 weeks with medical supervision

Where to Buy

Purchase authentic Pharmacom Labs Sibutramine 15mg x 50 tablets exclusively from verified pharmaceutical suppliers
Source only from trusted research chemical vendors with established quality control
Verify product authenticity using batch numbers and hologram seals on Pharmacom Labs packaging
Legitimate vendors provide laboratory testing documentation confirming purity and dosage accuracy
Avoid unverified sources selling counterfeit weight loss compounds
Check expiration dates and tablet integrity before use
Reputable suppliers with third-party testing certification preferred

Safety Considerations

Sibutramine affects cardiovascular function and blood pressure. Medical supervision is mandatory. Not suitable for individuals with heart conditions, hypertension, or history of stroke. Can cause insomnia, dry mouth, and increased heart rate. Contraindicated with MAO inhibitors and certain antidepressants.